Overnight shipping is standard.
Now that the human genetic code has finally been deciphered, the rush is on to profit from the knowledge. This month, the U.S. Patent and Trademark Office is expected to finalize new, stricter standards that will determine when a company like Incyte can obtain a patent on a human gene. Incyte's executives believe that gene patents are good for business and science. When the pioneering genomics company started hunting for genes, in the early 1990s, it could not be sure it would be able to patent the genes it found. To protect its discoveries from poachers, Incyte shared its gene information only with big drug companies willing to sign detailed confidentiality clauses.